Acetylcholinesterase Inhibitors as Disease-Modifying Therapies for Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|15|24|2433-2455

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.24, 2008-10, pp. : 2433-2455

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protease inhibitors as potential disease-modifying therapeutics for Alzheimer’s disease

By Beher Dirk   Graham Samuel L  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 11, 2005-11 ,pp. : 1385-1409

Informa Healthcare

Access to resources Recommend Favorite

Disease-Modifying Therapies in Alzheimer's Disease: How Far Have We Come?

By Hüll Michael   Berger Mathias  

Drugs, Vol. 66, Iss. 16, 2006-01 ,pp. : 2075-2093

Adis International

Access to resources Recommend Favorite

Disease-Modifying Therapies for Osteoarthritis: Current Status

By Marc Fajardo   Paul E. Di Cesare  

Drugs & Aging, Vol. 22, Iss. 2, 2005-01 ,pp. : 141-161

Adis International

Access to resources Recommend Favorite

Disease-Modifying Therapies in Frontotemporal Lobar Degeneration

By  

Current Medicinal Chemistry, Vol. 19, Iss. 7, 2012-03 ,pp. : 1008-1020

Bentham Science Publishers

Access to resources Recommend Favorite

Disease-Modifying Approach to the Treatment of Alzheimer's Disease: From α-Secretase Activators to γ-Secretase Inhibitors and Modulators

By Panza Francesco  

Drugs & Aging, Vol. 26, Iss. 7, 2009-07 ,pp. : 537-555

Adis International

Access to resources Recommend Favorite